Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5-year follow-up data from the prospective BioCrohn study.
Bernd BokemeyerSandra Plachta-DanielzikRomina di GiuseppeUlf HelwigNiels TeichCarsten SchmidtPetra HartmannChristina SobotzkiStefan SchreiberPublished in: Alimentary pharmacology & therapeutics (2023)
An additional bidirectional disease behaviour assessment capturing reversed or fully controlled complications may provide a more realistic appraisal of the complexity and unmet needs of patients treated with advanced therapies.